| 121/553 | US=16 / Câncer Pagano JS. Molecular pathobiology of EBV infection. In: Khalili K, Jeang KT. Viral oncology: basic science and clinical applications. New Jersey: Wiley-Blackwell, 2010. p. 409-23. ISBN 978-0-470-37991-2. VIRUS EPSTEIN-BARR; LINFOMA DE BURKITT; LINFOMAS IMUNOBLASTICOS; LINFOMAS DE HODGKIN; CARCINOMA NASOFARINGEO; CARCINOMA GASTRICO; CANCER DE MAMA; LEIOMIOSARCOMA |
| 122/553 | US=16 / Câncer Dar WA, Sugden B. Epstein-Barr virus as a pathogen. In: Khalili K, Jeang KT. Viral oncology: basic science and clinical applications. New Jersey: Wiley-Blackwell, 2010. p. 425-51. ISBN 978-0-470-37991-2. VIRUS EPSTEIN-BARR; AIM; DOENCA LINFOPROLIFERATIVA POS-TRANSPLANTE; LINFOMA DE HODGKIN; LINFOMA DE BURKITT; LEUCOPLASIA PILOSA ORAL; CARCINOMA NASOFARINGEO |
| 123/553 | US=6 / Quimioterapia Airley R. Cancer epidemiology. In: ___. Cancer chemotherapy: basic science to the clinic. New Jersey: John Wiley & Sons, 2009. p. 1-10. ISBN 978-0-470-09254-5. EPIDEMIOLOGIA DO CANCER; INCIDENCIA DO CANCER; CANCER NA INFANCIA; INCIDENCIA DE MORTALIDADE |
| 124/553 | US=6 / Quimioterapia Airley R. Histopathology of cancer. In: ___. Cancer chemotherapy: basic science to the clinic. New Jersey: John Wiley & Sons, 2009. p. 11-8. ISBN 978-0-470-09254-5. HISTOPATOLOGIA DO CANCER; TECIDOS BENIGNO; TECIDOS MALIGNO NORMAIS; MORTE CELULAR |
| 125/553 | US=6 / Quimioterapia Airley R. Carcinogenesis, malignant transformation and progression. In: ___. Cancer chemotherapy: basic science to the clinic. New Jersey: John Wiley & Sons, 2009. p. 19-21. ISBN 978-0-470-09254-5. TRANSFORMACAO; CARCINOGENESE; PROGRESSAO MALIGNA; CARCINOGENESE QUIMICA |
| 126/553 | US=6 / Quimioterapia Airley R. Molecular biology of cancer: oncogenes and tumour suppressor genes. In: ___. Cancer chemotherapy: basic science to the clinic. New Jersey: John Wiley & Sons, 2009. p. 23-35. ISBN 978-0-470-09254-5. BIOLOGIA MOLECULAR DO CANCER; ONCOGENESE; GENES SUPRESSORES TUMORAIS |
| 127/553 | US=6 / Quimioterapia Airley R. Tumour metastasis: a convergence of many theories. In: ___. Cancer chemotherapy: basic science to the clinic. New Jersey: John Wiley & Sons, 2009. p. 37-48. ISBN 978-0-470-09254-5. TUMOR PRIMARIO; METASTASE DO TUMOR; TRANSPORTE; EXTRAVASAMENTO; CRESCIMENTO DA MASSA DO TUMOR METASTATICO |
| 128/553 | US=6 / Quimioterapia Airley R. Health professionals in the treatment of cancer. In: ___. Cancer chemotherapy: basic science to the clinic. New Jersey: John Wiley & Sons, 2009. p. 49-54. ISBN 978-0-470-09254-5. PROFISSIONAIS DE SAUDE NO TRATAMENTO DE CANCER; ONCOLOGISTA CIRURGICO. VISAO; FARMACIA EM ONCOLOGIA; ENFERMAGEM ONCOLOGICA; CANCER NHS |
| 129/553 | US=6 / Quimioterapia Airley R. Principles of cancer chemotherapy. In: ___. Cancer chemotherapy: basic science to the clinic. New Jersey: John Wiley & Sons, 2009. p. 55-65. ISBN 978-0-470-09254-5. PRINCIPIOS DA QUIMIOTERAPIA; TEMPORIZACAO DA QUIMIOTERAPIA; FARMACOGENETICA; FARMACOGENOMICA DE QUIMIOTERAPIA |
| 130/553 | US=6 / Quimioterapia Airley R. Classical anticancer agents. In: ___. Cancer chemotherapy: basic science to the clinic. New Jersey: John Wiley & Sons, 2009. p. 67-115. ISBN 978-0-470-09254-5. CLASSICOS AGENTES ANTICANCERIGENOS; AGENTE SUILANTES; ANTIMETABOLITOS; ANTIBIOTICOS ANTITUMORAIS; PRODROGAS ANTRACICLINA; SULCO DE LIGACAO DE AGENTES; INIBIDORES DA TOPOISOMERASE; INIBIDORES MITOTICOS; HORMONAIS AGENTES ANTICANCERIGENOS; REGIMES DE QUIMIOTERAPIA |
| 131/553 | US=6 / Quimioterapia Airley R. The philosophy of cancer research. In: ___. Cancer chemotherapy: basic science to the clinic. New Jersey: John Wiley & Sons, 2009. p. 117-23. ISBN 978-0-470-09254-5. PESQUISA DO CANCER; PESQUISA DO CANCER NO REINO UNIDO; PESQUISA SOBRE O CANCER NOS ESTADOS UNIDOS |
| 132/553 | US=6 / Quimioterapia Airley R. Novel anticancer agents. In: ___. Cancer chemotherapy: basic science to the clinic. New Jersey: John Wiley & Sons, 2009. p. 125-65. ISBN 978-0-470-09254-5. AGENTES ANTICANCERIGENOS; MANIPULACAO GENETICA DE LINHAS CELULARES; CELULAS TUMORAIS SHEROIDS; DROGAS DE CHUMBO; TRIAGEM; ATIVIDADE ANTICANCERIGENA IN VITRO; XENOENXERTOS TUMORES |
| 133/553 | US=6 / Quimioterapia Airley R. Clinical trials. In: ___. Cancer chemotherapy: basic science to the clinic. New Jersey: John Wiley & Sons, 2009. p. 167-75. ISBN 978-0-470-09254-5. EVOLUCAO NO TRATAMENTO; ENSAIOS CLINICOS; AVALIACAO DA VASCULARIZACAO; ANGIOGENESE PELA TECNOLOGIA DE MEDICINA NUCLEAR |
| 134/553 | US=6 / Quimioterapia Airley R. Tumour hypoxia. In: ___. Cancer chemotherapy: basic science to the clinic. New Jersey: John Wiley & Sons, 2009. p. 177-98. ISBN 978-0-470-09254-5. |
| 135/553 | US=6 / Quimioterapia Airley R. Antiangiogenic and antivascular agents. In: ___. Cancer chemotherapy: basic science to the clinic. New Jersey: John Wiley & Sons, 2009. p. 199-216. ISBN 978-0-470-09254-5. AGENTES ANTIANGIOGENICOS; AGENTES ANTIVASCULAR; HISTORIA DA ANGIOGENESE; ANTI-ANGIOGENICOS; TALIDOMIDA; ANTICORPOS; AGENTES ANTIANGIOGENICOS; AGENTES PERTURBADORES |
| 136/553 | US=6 / Quimioterapia Airley R. Tyrosine kinase inhibitors. In: ___. Cancer chemotherapy: basic science to the clinic. New Jersey: John Wiley & Sons, 2009. p. 217-23. ISBN 978-0-470-09254-5. INIBIDORES DA QUINASE DE TIROSINA; NAO-RECEPTOR INIBIDORES DE TIROSINA |
| 137/553 | US=6 / Quimioterapia Airley R. Ras inhibitors. In: ___. Cancer chemotherapy: basic science to the clinic. New Jersey: John Wiley & Sons, 2009. p. 225-8. ISBN 978-0-470-09254-5. |
| 138/553 | US=6 / Quimioterapia Airley R. Inhibitors of the AKT/PKB pathway. In: ___. Cancer chemotherapy: basic science to the clinic. New Jersey: John Wiley & Sons, 2009. p. 229-31. ISBN 978-0-470-09254-5. |
| 139/553 | US=6 / Quimioterapia Airley R. Targeting stress proteins: HSP90 inhibitors. In: ___. Cancer chemotherapy: basic science to the clinic. New Jersey: John Wiley & Sons, 2009. p. 233-6. ISBN 978-0-470-09254-5. |
| 140/553 | US=6 / Quimioterapia Airley R. The proteasome. In: ___. Cancer chemotherapy: basic science to the clinic. New Jersey: John Wiley & Sons, 2009. p. 237-43. ISBN 978-0-470-09254-5. |